ohappa is Cinclus Pharma's full-service agency, acting as an external communications department supporting various functions within the company – primarily the CEO and CFO.
Key elements of the assignment:
Biotech company Cinclus Pharma is developing a new drug for the treatment of gastric acid and reflux diseases, which affect millions of people worldwide. With the drug candidate linaprazan glurate, Cinclus Pharma takes the Swedish medical heritage in gastric medicine to a new level.
The company has a team with impressive expertise. Several of the employees have a background in AstraZeneca as part of the development of global bestsellers such as Losec and Nexium. The head office is located in Stockholm.
"ohappa is easy and professional to work with. Thanks to their experience, drive and creativity, ohappa helps us keep up the pace of our communication work and ensures that we maintain a high level of design in everything we do."
Christer Ahlberg, CEO, Cinclus Pharma